Christophe Blanquart

14PUBLICATIONS
31CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersGene and molecular therapyNanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 17, 2026
Optimising response to immunotherapies in pleural mesothelioma: clinical data and alternative models for the evaluation of new strategies.

Christophe Blanquart, Arnaud Scherpereel

|Sep 24, 2025
Pharmacogenomic Characterization of a Large Cohort of Patient-Derived Cell Lines Identifies Therapeutic Strategies for Pleural Mesothelioma.

Jean-Baptiste Assié, Clément Meiller, Esther Stern

|Oct 16, 2024
Loss of miR-200c-3p promotes resistance to radiation therapy via the DNA repair pathway in prostate cancer.

Maureen Labbé, Manon Chang, Benjamin Saintpierre

|Jan 25, 2024
Specific Targeting of Mesothelin-Expressing Malignant Cells Using Nanobody-Functionalized Magneto-Fluorescent Nanoassemblies.

Tina Briolay, Judith Fresquet, Damien Meyer

|Dec 01, 2022
Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition.

Sabine Paternot, Eric Raspé, Clément Meiller

|Oct 12, 2022
Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment.

Ananya Hariharan, Weihong Qi, Hubert Rehrauer

Pageof 3

Frequent Collaborators

3 joint publications

Delphine Fradin

3 joint publications

Didier Jean

1 joint publications

Pierre Autin

1 joint publications

Lucas Treps